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Abstract  An emphasize on herbal medicine in cancer therapy is also included as an 
example of translational research implementation. A translational research in 
Faculty of Medicine, Universitas Padjajaran, has been conducted to develop a 
novel genomic approach (herbal genomic) on herbal crude extracts. This study 
focuses on the effects of the extracts on specific gene expressions. In this aspect, 
the concept of molecular targets is slightly different from pharmaceutical 
approaches  that aim to find compounds that interact with a specific molecule 
or macromolecule with known function. In this research strategy, the herbal 
genomic approaches involve screening of herbal extracts that affect particular 
gene expression related to cell responses rather than a single proteins. The 
determination of herbal concentration is based on differential gene expression 
before and after treatment which is analyzed by real time PCR. The results are 
being compared to the existing small molecule (active molecule) on the gene 
expressions. All these academic activities require biomedical research workforce 
to implement the translational research which, in the Faculty of Medicine, 
Universitas Padjadjaran, is fulfilled by involving the postgraduate students. 
New crude extract formulation plus specific gene expression profile is a concept 
required for developing chemotherapeutic agent in Indonesia. Hopefully, this 
review can support increased cooperation between hospital and academic 
institutions in implementing translational research in Indonesia. 
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Introduction 
The global health program is very popular 
in the millennium development era because 
it proposes efforts to improve the health of 
people in many countries, including for diseases 
typically associated with advanced economics. 
Varmus and Timble have analyzed that the 
program is directed towards diseases-related 
problems in developing countries including those 
related to infectious diseases and nutritional 
deficiencies.1 The increased number of cancer 
deaths in developing countries has also drawn 
the attention of the health community in the 
world. We are interested in the epidemiological 
data shown by Vermus and Timble that 25% of 
life threatening cancers in the developing world 
are caused by infections.1 Despite the fact that 
successful effective prevention efforts for some 
infectious diseases and therapy for cancer have 
been implemented, they are not adequate yet 
to satisfy the community needs, especially in 
Indonesia. This situation affords an opportunity 
to create innovations in our strategy to develop 
translational research in order to strengthen the 
vision of “from bench to bedside” which focuses 
on oncology and infection.
From the perspective of the government 
policy to develop and increase the utilization of 
generic drugs in Indonesia, the use of natural 
resources that takes in the form of traditional 
medicine is strongly recommended. Still, clinical 
trials to provide strong evidence supporting 
this national commodity in medicine should be 
conducted. With this policy, it is expected that 
the needs for affordable medicine among people 
of Indonesia can be met and domestic medical 
industries will grow.
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This review describes studies that are based 
on current gene expression science in herbal 
chemotherapeutic development. The focus of 
this review is herbal medicines that can be tested 
and applied in clinical trials through translational 
research.
Cancer or neoplasm is a group of diseases with 
multifactorial etiologies that causes abnormal 
cell proliferation. Basically, cancer is caused by 
abnormalities in cell cycle and its regulations 
which are organized by specific proteins coded 
by specific genes. The development of natural 
products for cancer therapy in Indonesia has not 
shown any progress in terms of clinical trials, 
which leads to a situation where almost all 
cancer therapies depend on imported products. 
The barriers in developing cancer therapy in 
Indonesia are due to rigid strategy of using the 
bioactive form of the natural products where 
the modern medicine is only based on the active 
molecule. This approach is time consuming and 
needs high budget to obtain optimal results. In 
addition, the cell death and survival pathways 
have not yet completely elucidated when the 
avoidance of some specific types of cell death 
in cancer is very important to prevent injury in 
normal cells.2,3
Some cancers are drug resistant and others 
tend to relaps. This indicates that the cell deaths 
associated to the cell survival pathway do not 
involve a single pathway only, which leads to 
difficulties in killing cancer cells. Therefore, 
the cancer treatment cannot rely on a single 
active compound and should be based on a 
combination therapy to eliminate cancer cells.
Enthusiasm on developing natural products 
as therapeutic agents in cancer has grown in 
Indonesia, especially for natural sources that are 
already known as having anticancer activities. 
However, the scientific aspect of it has not been 
tested yet. This problem is not easy to solve 
and a multi-discipline cooperation is needed, 
both from basic and applied sciences. This will 
be an opportunity to innovate by integrating 
translational research into the ongoing studies.
The Global Concept of Herbals Development 
in Medicine
Herbal medicine is made of natural substances 
containing small molecules, macromolecules, 
and complex molecules/crude extracts. It has 
been noted that 60% of the approved regimens 
used for treating cancer are derived from natural 
sources.4,5 Traditional Indonesian medicine is a 
well-known herbal decoctions and consumed 
by many people in Indonesia as a supplement 
for maintaining their health. Unfortunately, 
information on their mechanism and potential 
drug ability is limited making it difficult to 
develop herbal medicine. Herbal decoctions can 
nourish the body holistically and support various 
organ systems.6 The general concept of this 
phenomenon is based on natural products and 
tissue/organ interaction (Fig. 1) which can be 
studied from the gene expression perspective, 
resulting in opportunities for future research and 
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development. Furthermore, the scheme shows 
that natural products and cellular component 
interactions and in vivo gene expression analysis 
perspective can be continued into a clinical 
trial program. On the other hand, after the 
in vivo experiment is conducted, the herbal 
medicine can be developed based on the new 
functions found in the crude extracts. A research 
program that includes characterization and 
identification of natural products supported by 
gene expression interaction to promote new 
molecular target and herbal formulations is 
also available. Jain used natural products for 
treating cancer and they listed name of herbs 
associated with method and use for cancer 
treatment including Phyllanthus niruri and Vitis 
vinifera.7 Jang published the natural product 
derived from grape’s resveratrol having chemo-
preventive activity.8 Both Phyllanthus niruri and 
Vitis vinifera are investigated in our research 
program as a single agent and combination to 
treat cancer cells. 
In recent years, it has been reported that many 
natural substances have been used for prevention 
and treatment of various degenerative diseases, 
such as diabetes, hypertension, obesity, cancer, 
and other similar diseases.9-12 Colic and Pavelic 
reported their research about natural compounds 
with multifunctional activity and promoted both 
cytostatic and cytotoxic activities towards cancer 
cells.13 Historically, human choose non-toxic 
vegetable or plants. It means in human intestine 
or gastrointestinal tract, the plant will be 
digested into small molecules, macromolecules 
and/or still in complex molecules that meet 
body requirements (Fig. 2). These molecules 
enter blood circulation and interact with target 
cell by binding cell surface proteins or enter the 
cytoplasma to bind with specific proteins. These 
scientific facts show that although there are 
many molecules surrounding the outer part of 
the cell target, only few are able to enter the cell 
and interact with specific receptors or proteins. 
These interactions trigger the corresponding 
pathways and cellular responses. In cancer cell, 
many possible cellular responses will appear, 
such as cell death, cell silence, cell resistance, cell 
migration, cell competition, cell survival, and cell 
senescence. Each cellular response will impact 
related organs/tissues. Therefore, it is possible 
to expand global health from gene expressions 
to personalized health care.
This finding is particularly interesting in terms 
that the functional assay was used to evaluate 
inhibitory effect of this herbal crude extract on 
cell proliferation compared to the same effect 
of chemotherapeutic agents (doxorubicin and 
cisplatin). 
The Scientific Aspects of Herbal Genomic
It has been identified by the scientific community 
that important issues related to herbal medicine 
should be addressed to retain the best of the 
current academical research strategy including 
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avoiding stagnant basic theories and supporting 
the need of clinical trials. It is noted by Nilsen and 
Bierer that the translational medical research is 
an important, legitimate, and necessary effort for 
scientists in universities and research hospitals.14 
Interestingly,  a central goal of academic medical 
institutions is to ensure that their innovation 
ultimately benefit patients. A tentative design 
that combines both traditional and modern 
medicine including its pharmaceutical approach 
in equal share is shown (Fig. 3). An overlapped 
area of both circles containing herbal genomics 
is seen. This herbal genomics cover the scientific 
issues starting from genome to the cellular 
responses. The herbal genomics are embedded 
into both traditional and modern medicines.
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Fig. 3 Herbal Genomics as a Mediator 
between Traditional and Modern 
Medicine Strategy
The profile of gene expressions is used as an 
indicator of the effective dose of related herbal 
extract to inhibit cell proliferation or increase 
cell death. This molecular level interaction has 
been implemented to determine effective dose 
of herbal crude extract.15
The characterization and identification 
of  the natural products may involve various 
molecule types including small molecules, 
macromolecules and complex molecules (Fig. 1). 
These substances are going to be analyzed and 
developed by pharmaceutical approaches such 
as clinical trials that are targetted to a single 
protein or a single molecule. Our concept uses 
herbal products as a crude extract formulation 
relying on gene expressions leading to cellular 
responses and not only a single protein. If this 
product can be tested in vivo, a crude extract as 
an anti-cancer can be created. Gene expressions 
which play a role in cell cycle and other genes 
associated with cell death (apoptosis, necrosis, 
autophagy) will be analyzed.
The scientific aspects of this approach include 
the use of molecular biology concept based 
on interactions between herbal extracts and 
the cellular components of cancer cell as the 
molecular target that affects gene expressions. 
These targets can only be gained by determining 
the concentration of each herbal component 
compared to the cancer drugs such as cisplatin 
and doxorubicin. The equality of concentration 
of cisplatin and doxorubicin in killing the cancer 
cells by using gene expressions will be used as an 
indicator to determine the concentration of the 
herbs combination. Gene expressions are going 
to be measured based on the quantity of RNA 
molecules using real time PCR. Gene expression 
based herbal formula is not yet generally known 
in Indonesia and they will be developed as an 
oral powder prototype. This will be an excellent 
innovation in the national scientific community, 
which should be proposed to get  a patent right, 
to fulfill the need for cancer therapeutic agent in 
Indonesia.
Those innovations above are currently listed 
in the phase 1 of the translational research in the 
Faculty of Medicine, Universitas Padjadjaran. The 
research program is designed in three phases. 
The first phase is the laboratory and animal 
experiments based on basic theories to build 
a foundations for the next phases. This will be 
followed by the second phase, that includes in 
vivo experiments to determine a formula which 
is harmless and beneficial for human being. The 
third phase includes several types of clinical 
trials. After completing all phases, the formula 
will be used in health care. In this regards, an 
entrepreneurship strategy will also be needed. 
This research strategy may be slightly different 
from Khoury et al.16 These initiatives are intended 
to integrate and develop a system for learning, 
comparative effective research, as well as quality 
health care and generating additional hypothesis 
for future investigations.
Chemical Compounds of Crude Extract and 
Their Actions on Selective Pathway 
The use of traditional medicine in Indonesia is 
not an unfamiliar part of disease treatment in 
the community. Unfortunately, its development 
cannot compete with modern medical science 
which prioritizes on active molecule substances 
as a center of treatment mechanism. The author 
wanted to increase the utilization of natural 
resources of Indonesia in the form of crude 
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extracts. Due to limited human and financial 
resources, it is difficult for Indonesia to obtain 
the active compounds to achieve the ideal 
results. Historically, it has been noted that 
most people in daily treatment of disease use 
herbal medicine in the form of crude extracts 
and experience a positive effect on certain 
clinical symptoms. Indeed, we are very familiar 
with the superiority of the active compound in 
medicine where the molecular interactions can 
be obviously observed and the dosage can also 
be determined accurately. In respond to this 
scientific requirement, laboratory results from 
the studies on the effects of herbal medicine in 
the form  of crude  extracts  on  inhibiting  cancer 
cell proliferation by analyzing gene expression 
were referred to the IC50.15 These molecular 
data can  explain the response of a cell and the 
pathway that is activated or inhibited  by natural 
compounds. For certain disease, especially 
degenerative disease such as  cancer, the activities 
of more than one type of signal transductions 
and pathways are always involved and it may 
even comprise a series of reactions that  also 
have multiple or more than one pathway. It is 
debated whether a single active substance can 
act on so many different biochemical pathways 
in the cell target. It can be understood that all 
signs and symptoms of the disease are not 
pathogenically resulted from the work of a 
single molecule, but from tens or hundreds 
of molecules and even tens of biochemical 
pathways. Although, the modern medicine and 
the pharmaceutical approach  have  been  able 
to determine the pathway of the biochemical 
reactions by targeting a specific molecule as a 
key molecule that effect the pathway, the cellular 
pathway is not a single process but always 
associated with other reactions or networks. 
Thus, the question whether a single active 
substance is able to inhibit the whole reactions 
or pathways in cancer cells. In fact, there is no 
single chemotherapeutic agent being able to 
recover completely the cancer patients. This 
leads to the notion that at the molecular level 
the body is naturally governed by many reaction 
mechanisms. This molecular process extends the 
research that can  be  categorized  as a gene to 
protein level research through gene expressions. 
These processes aim to maintain homeostasis. 
Thus, even if an active substance is required, it 
would still be necessary to combine it with other 
active substances. Based on that idea, we should 
be able to develop herbal crude extracts with 
equal effect to active compounds and focus on 
molecular targets. If this can be implemented, 
the development of crude  extract in medicine 
will have similar quality with modern medicine 
although it is still on the level of crude extract. 
This strategy is important for the development 
of generic drugs in Indonesia. A cell could be 
surrounded by various molecules contained in 
the crude extract (Fig. 4). The substance varies 
from large molecules or complex molecules  to 
small molecules. These molecules will interact 
with their respective receptors on the cell 
membrane, cytoplasm or cell nucleus. The 
results from our studies on HeLa cells showed 
that the crude extract conferred inhibition of cell 
proliferation (IC50).15–22
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It is already well known that the use of the 
crude extract with various molecules will result 
in a variety of cellular responses. By setting the 
optimal dosage and making comparison with 
the existing commercial chemotherapeutic 
agent as a marker, a target for cancer therapy 
will  be obtained and unwanted effects can be 
minimized. The implementation of this strategy 
to treat cancer cells can be analyzed using IC50 
determination.
From Bench to Bedside
With the outcomes of the study conducted in 
Faculty of Medicine, Universitas Padjadjaran, 
that combines basic, clinical and public health 
sciences, some new discoveries have been made. 
However, moving the scientific discoveries of 
herbal medicine into clinical trials have always 
been slow, expensive, and difficult achieved.17 
It is not surprising that even in the developed 
countries it takes an average of 17 years for 
herbal medicine to enter day to day clinical 
practice, and that is only for 14% of all new 
scientific discoveries.18 A study by Contopolous 
showed that only 5% of highly promising basic 
science findings were licensed for clinical use 
and only 1% were actually used for the licensed 
indication.19 Therefore, there are several key 
questions to be asked: Is translational medicine 
research important in Indonesia? What should 
the role of the Health Department of Republic 
of Indonesia be in supporting clinical trial 
originating from university research program? In 
this matters, we support Meyers and Pomeroy 
that knowledge and technology that produce 
sustainable improvements in health and quality 
of life begin with early translational research 
efforts and are in need of biomedical research 
workforce.20
Sung described some barriers to translational 
research that range from a lack of willing 
participants to the lack of funding.21 In Indonesia, 
little is known about translational research in 
medicine that transfer new understanding of 
disease mechanisms gained in basic laboratories 
into the development of new methods for 
diagnosis, therapy and prevention, as well as the 
clinical trials in hospitals.
Goldblatt and Lee mentioned in their article 
that primary goal of translational research is 
to integrate progresses in molecular biology 
with clinical trials, taking research from “bench 
to bedside”.22 In this review on translational 
research, a description on the effects of herbal 
medicine in the form of crude extracts to inhibit 
cancer cell proliferation has been given and a gene 
expression analysis is currently performed in the 
Faculty of Medicine, Universitas Padjadjaran, 
to create a chemotherapeutic agent. The team 
has introduced a new terminology of herbal 
medicine, namely herbal genomics. This new 
terminology can be used in recent clinical 
campaigns for traditional medicine including 
for herbal chemotherapeutic development 
that addresses crude extract and genomic 
analysis. In this analysis, a IC50 determination 
of Phyllanthus niruri and Vitis vinifera that were 
designed for complementary therapy of cancer 
were performed.23 These systematic efforts of 
translat ional research will increase extensive 
cooperation between basic researchers, 
clinicians and industries that integrate basic 
sciences into human health in Indonesia.
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